JPH0454651B2 - - Google Patents

Info

Publication number
JPH0454651B2
JPH0454651B2 JP58167339A JP16733983A JPH0454651B2 JP H0454651 B2 JPH0454651 B2 JP H0454651B2 JP 58167339 A JP58167339 A JP 58167339A JP 16733983 A JP16733983 A JP 16733983A JP H0454651 B2 JPH0454651 B2 JP H0454651B2
Authority
JP
Japan
Prior art keywords
labeled
iodine
metaraminol
preparation
radioactive iodine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58167339A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6058927A (ja
Inventor
Akira Yokoyama
Yoshiaki Oomomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Priority to JP58167339A priority Critical patent/JPS6058927A/ja
Priority to US06/564,653 priority patent/US4619823A/en
Priority to CA000444443A priority patent/CA1222451A/en
Priority to AU22998/83A priority patent/AU561695B2/en
Publication of JPS6058927A publication Critical patent/JPS6058927A/ja
Publication of JPH0454651B2 publication Critical patent/JPH0454651B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP58167339A 1983-09-09 1983-09-09 放射能標識血小板製剤 Granted JPS6058927A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP58167339A JPS6058927A (ja) 1983-09-09 1983-09-09 放射能標識血小板製剤
US06/564,653 US4619823A (en) 1983-09-09 1983-12-22 Radioactive iodine labeled metaraminol and diagnostic agent containing platelets labeled therewith
CA000444443A CA1222451A (en) 1983-09-09 1983-12-29 Radioactivity-labeled platelet preparation
AU22998/83A AU561695B2 (en) 1983-09-09 1983-12-30 Radioactive iodine labeled metaraminol for diagnostic purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58167339A JPS6058927A (ja) 1983-09-09 1983-09-09 放射能標識血小板製剤

Publications (2)

Publication Number Publication Date
JPS6058927A JPS6058927A (ja) 1985-04-05
JPH0454651B2 true JPH0454651B2 (en, 2012) 1992-08-31

Family

ID=15847896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58167339A Granted JPS6058927A (ja) 1983-09-09 1983-09-09 放射能標識血小板製剤

Country Status (4)

Country Link
US (1) US4619823A (en, 2012)
JP (1) JPS6058927A (en, 2012)
AU (1) AU561695B2 (en, 2012)
CA (1) CA1222451A (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US5334369A (en) * 1991-06-11 1994-08-02 Medical University Of South Carolina Platelet receptor antagonists useful in detecting intravascular platelet aggregation
US7049140B1 (en) * 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US7306925B2 (en) * 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
KR101106533B1 (ko) * 2003-07-24 2012-01-20 브라코 이미징 에스.피.에이. 안정한 방사성의약 조성물 및 제조 방법
WO2006028993A2 (en) * 2004-09-02 2006-03-16 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1995709A (en) * 1931-09-22 1935-03-26 Sharp & Dohme Inc Hydroxyphenylpropanolamine hydrochloride
FR6087M (en, 2012) * 1967-01-10 1968-06-04
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
DE2427659C3 (de) * 1974-06-07 1979-08-16 Byk-Mallinckrodt, Chemische Produkte Gmbh, 6057 Dietzenbach Verfahren zur Herstellung von radioaktiv markierten Erythrozyten
US4298591A (en) * 1979-04-03 1981-11-03 The United States Of America As Represented By The United States Department Of Energy Instantaneous radioiodination of rose bengal at room temperature and a cold kit therefor
US4430319A (en) * 1982-05-21 1984-02-07 State University Of New York Radioactive iodine labeled phenolic amines

Also Published As

Publication number Publication date
CA1222451A (en) 1987-06-02
US4619823A (en) 1986-10-28
AU561695B2 (en) 1987-05-14
AU2299883A (en) 1985-04-18
JPS6058927A (ja) 1985-04-05

Similar Documents

Publication Publication Date Title
CA2109208C (en) Radiolabeled metal-binding protein for the treatment of arthritis
US5219556A (en) Stabilized therapeutic radiopharmaceutical complexes
EP0273452B1 (en) High molecular compound comprising unit of asialoglycoprotein acceptor-directing compound and unit of chelate-forming compound chemically bonded thereto, and its utilisation
US4401647A (en) Radiolabeled neoglycopeptides
JPS5813524A (ja) 血栓の位置決定用組成物
JPH036124B2 (en, 2012)
US4935222A (en) Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
JPH0454651B2 (en, 2012)
US4443426A (en) Blood agent
KR860001565B1 (ko) 방사성 진단제의 제조방법
US4564472A (en) 3-Aminomethylene-2,4-pentanedione bis(thiosemicarbazone) derivatives, and their production and use
JPS5925802A (ja) 新規なヘパリン化合物
US4284619A (en) Esters useful as brain imaging agents
Chiotellis et al. Preparation of Tc-99m labeled pyridoxal-amino acid complexes and their evaluation
EP0107452B1 (en) Improvements in or relating to imaging agents
US4448762A (en) Complex of transferrin with ruthenium for medical applications
US4406875A (en) Radiolabeled amine compounds and their use
AU609569B2 (en) Tc-99m mononuclide complex compound
JP2564459B2 (ja) 放射性医薬品調製用キャリヤー
JPH0416465B2 (en, 2012)
JPH0615478B2 (ja) 放射性医薬品とその調製用高分子化合物
JPH0433767B2 (en, 2012)
JPH10512852A (ja) 放射性標識化アネキシン−ガラクトースクラスター複合体
JPH0460974B2 (en, 2012)
JPS63170389A (ja) 放射性医薬品とその調製用高分子化合物